Watch the experts discuss additional SKYRIZI study results:
Professors Strober and Van de Kerkhof, two expert dermatologists, discuss the IMMhance PsO trial.
Professor Kim Papp, principal investigator of KEEPsAKE-1 and -2, summarizes the results of the Phase 3 PsA studies.
Dr. Richard Warren, an expert dermatologist, discusses data from the IMMerge PsO study.
See Dr. Chi-ho Hong discuss his experience with the LIMIitless OLE
You may also be interested in
Find out more about SKYRIZI
Reference
- SKYRIZI [Summary of Product Characteristics]. AbbVie Ltd; February 2023.